Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 266-272

  Tsuda, Hidetoshi ^a   Kawada, Noritaka ^a   Kaimori, Jun Ya ^a   Kitamura, Harumi ^a   Moriyama, Toshiki ^a   Rakugi, Hiromi ^a   Takahara, Shiro ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Febuxostat; Ischemia reperfusion injury; Kidney

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ACTIVATING TRANSCRIPTION FACTOR 4; ALPHA SMOOTH MUSCLE ACTIN; FEBUXOSTAT; GLUCOSE REGULATED PROTEIN 78; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOPLASMIC RETICULUM STRESS; HISTOPATHOLOGY; KIDNEY CELL; KIDNEY ISCHEMIA; KIDNEY TUBULE; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THERAPY EFFECT;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; HYPERURICEMIA; KIDNEY; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THIAZOLES; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

RATTUS;

EID: 84867883322     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.032     Document Type: Article

References (22)

1. Gueler F., Gwinner W., Schwarz A., Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney Int. 2004, 66:523-527.
2. Paller M.S., Hoidal J.R., Ferris T.F. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 1984, 74:1156-1164.
3. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 1985, 312:159-163.
4. Ding W., Yang L., Zhang M., Gu Y. Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells. Biochem. Biophys. Res. Commun. 2012, 418:451-456.
5. Inagi R. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp. Nephrol. 2009, 112:e1-e9.
6. Ni M., Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Lett. 2007, 581:3641-3651.
7. Galbusera C., Orth P., Fedida D., Spector T. Superoxide radical production by allopurinol and xanthine oxidase. Biochem. Pharmacol. 2006, 71:1747-1752.
8. Massey V., Komai H., Palmer G., Elion G.B. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. J. Biol. Chem. 1970, 245:2837-2844.
9. Mohiuddin I., Chai H., Lin P.H., Lumsden A.B., Yao Q., Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J. Surg. Res. 2006, 133:143-149.
10. Racasan S., Turkstra E., Joles J.A., Koomans H.A., Braam B. Hypoxanthine plus xanthine oxidase causes profound natriuresis without affecting renal blood flow autoregulation. Kidney Int. 2003, 64:226-231.
11. Paul-Clark M.J., McMaster S.K., Sorrentino R., Sriskandan S., Bailey L.K., Moreno L., Ryffel B., Quesniaux V.F., Mitchell J.A. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am. J. Respir. Crit. Care Med. 2009, 179:299-306.
12. Gwinner W., Scheuer H., Haller H., Brandes R.P., Groene H.J. Pivotal role of xanthine oxidase in the initiation of tubulointerstitial renal injury in rats with hyperlipidemia. Kidney Int. 2006, 69:481-487.
13. Romagnoli M., Gomez-Cabrera M.C., Perrelli M.G., Biasi F., Pallardo F.V., Sastre J., Poli G., Vina J. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radical Biol. Med. 2010, 49:171-177.
14. Sakuma S., Negoro M., Kitamura T., Fujimoto Y. Xanthine oxidase-derived reactive oxygen species mediate 4-oxo-2-nonenal-induced hepatocyte cell death. Toxicol. Appl. Pharmacol. 2010, 249:127-131.
15. Lee W.Y., Lee S.M. Synergistic protective effect of ischemic preconditioning and allopurinol on ischemia/reperfusion injury in rat liver. Biochem. Biophys. Res. Commun. 2006, 349:1087-1093.
16. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., Galaris D.A. Uric acid and oxidative stress. Curr. Pharm. Des. 2005, 11:4145-4151.
17. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am. J. Physiol. Cell Physiol. 2007, 293:C584-C596.
18. Marciniak S.J., Yun C.Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H.P., Ron D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004, 18:3066-3077.
19. Kimura T., Takabatake Y., Takahashi A., Kaimori J.Y., Matsui I., Namba T., Kitamura H., Niimura F., Matsusaka T., Soga T., Rakugi H., Isaka Y. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 2011, 22:902-913.
20. Ogino K., Kato M., Furuse Y., Kinugasa Y., Ishida K., Osaki S., Kinugawa T., Igawa O., Hisatome I., Shigemasa C., Anker S.D., Doehner W. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ. Heart Fail. 2010, 3:73-81.
21. Sanchez-Lozada L.G., Tapia E., Soto V., Avila-Casado C., Franco M., Wessale J.L., Zhao L., Johnson R.J. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia. Nephron Physiol. 2008, 108:69-78.
22. Aslam S., Santha T., Leone A., Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int. 2006, 70:2109-2115.